Quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to Australia in 2015/16
In recent decades the range and patterns of opioids used for extra-medical purposes have changed. The use of pharmaceutical opioids exceeds the use of heroin. In 2017, 63 percent of opioid deaths were attributed exclusively to pharmaceutical opioids, 28 percent to illicit opioids and 8 percent to bo...
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Report |
| Language: | English |
| Published: |
2020
|
| Online Access: | http://hdl.handle.net/20.500.11937/81928 |
| _version_ | 1848764444996272128 |
|---|---|
| author | Makate, Marshall Whetton, Steve Tait, Robert Chrzanowska,, Agata Donnelly, Neil McEntee, Alice Muhktar, Aqif Zahra, Emma Campbell, Gabrielle Degenhardt, Louisa Dey, Tania Halim, Suraya Abdul Hall, Wayne Norman, Richard Peacok, Amy Roche, Ann Allsop, Steve |
| author_facet | Makate, Marshall Whetton, Steve Tait, Robert Chrzanowska,, Agata Donnelly, Neil McEntee, Alice Muhktar, Aqif Zahra, Emma Campbell, Gabrielle Degenhardt, Louisa Dey, Tania Halim, Suraya Abdul Hall, Wayne Norman, Richard Peacok, Amy Roche, Ann Allsop, Steve |
| author_sort | Makate, Marshall |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | In recent decades the range and patterns of opioids used for extra-medical purposes have changed. The use of pharmaceutical opioids exceeds the use of heroin. In 2017, 63 percent of opioid deaths were attributed exclusively to pharmaceutical opioids, 28 percent to illicit opioids and 8 percent to both illicit and pharmaceutical opioids (aged 15-64 years).
The objective of this report was to estimate the social costs arising from extra-medical opioid use in Australia for the financial year 2015/16. Due to data limitations in most cases we only estimated the costs occurring in this 12 month period. For example, on-going care of chronic conditions was not included. The exceptions to this were for certain harms which occurred in 2015/16 but which had longer-term ramifications, for example premature deaths, where discounted streams of future costs (lost economic activity and lost contributions to household chores) and partially offsetting savings (future health expenditure ’avoided’ by premature deaths) were estimated. The authors also included the long-term costs of road traffic accidents, as were the expected future costs of opioid attributable imprisonment for those sentenced in 2015/16. |
| first_indexed | 2025-11-14T11:19:28Z |
| format | Report |
| id | curtin-20.500.11937-81928 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-14T11:19:28Z |
| publishDate | 2020 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-819282021-06-24T04:28:06Z Quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to Australia in 2015/16 Makate, Marshall Whetton, Steve Tait, Robert Chrzanowska,, Agata Donnelly, Neil McEntee, Alice Muhktar, Aqif Zahra, Emma Campbell, Gabrielle Degenhardt, Louisa Dey, Tania Halim, Suraya Abdul Hall, Wayne Norman, Richard Peacok, Amy Roche, Ann Allsop, Steve In recent decades the range and patterns of opioids used for extra-medical purposes have changed. The use of pharmaceutical opioids exceeds the use of heroin. In 2017, 63 percent of opioid deaths were attributed exclusively to pharmaceutical opioids, 28 percent to illicit opioids and 8 percent to both illicit and pharmaceutical opioids (aged 15-64 years). The objective of this report was to estimate the social costs arising from extra-medical opioid use in Australia for the financial year 2015/16. Due to data limitations in most cases we only estimated the costs occurring in this 12 month period. For example, on-going care of chronic conditions was not included. The exceptions to this were for certain harms which occurred in 2015/16 but which had longer-term ramifications, for example premature deaths, where discounted streams of future costs (lost economic activity and lost contributions to household chores) and partially offsetting savings (future health expenditure ’avoided’ by premature deaths) were estimated. The authors also included the long-term costs of road traffic accidents, as were the expected future costs of opioid attributable imprisonment for those sentenced in 2015/16. 2020 Report http://hdl.handle.net/20.500.11937/81928 English fulltext |
| spellingShingle | Makate, Marshall Whetton, Steve Tait, Robert Chrzanowska,, Agata Donnelly, Neil McEntee, Alice Muhktar, Aqif Zahra, Emma Campbell, Gabrielle Degenhardt, Louisa Dey, Tania Halim, Suraya Abdul Hall, Wayne Norman, Richard Peacok, Amy Roche, Ann Allsop, Steve Quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to Australia in 2015/16 |
| title | Quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to Australia in 2015/16 |
| title_full | Quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to Australia in 2015/16 |
| title_fullStr | Quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to Australia in 2015/16 |
| title_full_unstemmed | Quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to Australia in 2015/16 |
| title_short | Quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to Australia in 2015/16 |
| title_sort | quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to australia in 2015/16 |
| url | http://hdl.handle.net/20.500.11937/81928 |